Please login to the form below

Not currently logged in
Email:
Password:

EADV congress

This page shows the latest EADV congress news and features for those working in and with pharma, biotech and healthcare.

New data keeps AbbVie’s star pipeline therapies on track

New data keeps AbbVie’s star pipeline therapies on track

At the European Academy of Dermatology and Venereology (EADV) Congress in Paris this week, the company reported outcomes data from three studies of its interleukin-23 inhibitor risankizumab in psoriasis – firming ... Lilly reported positive phase II

Latest news

  • Novartis' secukinumab has 'consistent' activity in psoriasis Novartis' secukinumab has 'consistent' activity in psoriasis

    The data - which was presented at the European Association of Dermatology and Venereology (EADV) Congress in Amsterdam this week - reinforces earlier studies suggesting that secukinumab was more effective in treating psoriasis ... Novartis reported

  • Trial success for Novartis' psoriasis drug

    Novartis has presented data at the European Academy of Dermatology and Venereology Congress that demonstrates investigational psoriasis treatment AIN457 is effective in up to 81 per cent of patients. ... Novartis has presented data at the European

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics